$IBB Company News Nasdaq action keeps speculators on

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
$IBB Company News

Nasdaq action keeps speculators on hold 2:27 p.m. Jan. 30, 2015 - The Trading Deck
Major U.S. benchmarks challenge last-ditch support 11:31 a.m. Jan. 20, 2015 - Michael Ashbaugh
Major U.S. benchmarks challenge last-ditch support 11:09 a.m. Jan. 20, 2015 - Michael Ashbaugh
Updates, advisories and surprises 12:31 p.m. Jan. 12, 2015 - MarketWatch
Celgene's stock rises, but off highs after profit outlook 11:49 a.m. Jan. 12, 2015 - Tomi Kilgore
More records for U.S. stocks as Dow tops 18,000 for first time 4:05 p.m. Dec. 23, 2014 - Anora Mahmudova
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 spikes from major support 11:32 a.m. Dec. 11, 2014 - Michael Ashbaugh
Charting the latest slow-motion breakout attempt 11:22 a.m. Dec. 4, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:51 a.m. Nov. 25, 2014 - Michael Ashbaugh
Strong bull trend reaches uncharted territory 11:29 a.m. Nov. 25, 2014 - Michael Ashbaugh
The trouble with fundamentals 1:38 p.m. Nov. 11, 2014 - The Trading Deck
Charting the S&P 500’s slow-motion breakout 11:00 a.m. Nov. 7, 2014 - Michael Ashbaugh
Amgen's stock drops after trial misses secondary endpoint 9:20 a.m. Nov. 4, 2014 - Tomi Kilgore
S&P, Nasdaq within striking distance of 50-day average 10:22 a.m. Oct. 24, 2014 - Michael Ashbaugh
Broadly-based snapback strengthens bull case 10:10 a.m. Oct. 22, 2014 - Michael Ashbaugh
U.S. stocks jump; Nasdaq enjoys best day in 21 months 3:38 p.m. Oct. 21, 2014 - Anora Mahmudova
U.S. benchmarks hesitate at major resistance 9:26 a.m. Oct. 20, 2014 - Michael Ashbaugh
Charting a failed retest of the 200-day average 10:16 a.m. Oct. 15, 2014 - Michael Ashbaugh
Tekmira CEO says being a biotech is like being in ‘shark-infested water’ 7:03 a.m. Oct. 8, 2014 - Wallace Witkowski


Barron’s Roundtable: Strategies for a New Age 2:46 p.m. Feb. 2, 2015 - Barrons.com
Some Pre-Earnings Release Observations About Gilead Sciences 11:02 a.m. Feb. 2, 2015 - Seeking Alpha
Is the 'January Effect' Signaling a Down Year for the Stock Market? 3:14 p.m. Jan. 30, 2015 - TheStreet.com
A Time To Cheer Or A Time To Cry 11:22 a.m. Jan. 30, 2015 - Seeking Alpha
IBB Is +34% For 1 Year And +7.31% For 2015 - But What Are The Risks? 10:07 a.m. Jan. 30, 2015 - Seeking Alpha
IShares Nasdaq Biotechnology ETF Experiences Big Outflow 10:53 a.m. Jan. 28, 2015 - TheStreet.com
Will You Miss The Netflix Ride To $1,000? 11:16 a.m. Jan. 27, 2015 - Seeking Alpha
Tech ETF IBB Brings Plenty Of Risk But It Fits Nicely In A Portfolio 10:14 a.m. Jan. 27, 2015 - Seeking Alpha
A New Biotech ETF Looks To Bring The Genomic Revolution To Investors 1:28 p.m. Jan. 23, 2015 - Seeking Alpha
Play the Biotech Boom With IBB 8:16 a.m. Jan. 21, 2015 - InvestorPlace.com
These 2 Charts Should Give Any Investor Pause 8:35 p.m. Jan. 20, 2015 - InvestorPlace.com
Will Mario Draghi Put A Floor Under Oil? 3:33 a.m. Jan. 19, 2015 - Seeking Alpha
Gilead: A Bullish Update 2:08 p.m. Jan. 16, 2015 - Seeking Alpha
A New Biotech ETF Targets Companies In Late Stage Clinical Trials 11:45 a.m. Jan. 16, 2015 - Seeking Alpha
ALPS Puts Twist On Biotech Investing With Medical Breakthrough ETF 12:48 a.m. Jan. 15, 2015 - Seeking Alpha
ALPS Puts Twist on Biotech Investing with Medical Breakthrough ETF - ETF News And Commentary 8:04 a.m. Jan. 14, 2015 - Zacks.com
Sidelines are Safest Until the Whipsaws End 8:19 p.m. Jan. 11, 2015 - InvestorPlace.com
'Fast Money' Recap: DJIA Cleans the Slate, Erases 2015 Losses 5:00 a.m. Jan. 9, 2015 - TheStreet.com
Kyle Bass's Assault On Pharma Patents 1:25 p.m. Jan. 8, 2015 - Seeking Alpha
FOMC, Oil Rebound Shake the Bulls Awake 11:30 a.m. Jan. 7, 2015 - InvestorPlace.com


Biotechs to Follow in 2015 off Fresh Insider Moves 10:01 a.m. Jan. 6, 2015 - ACCESSWIRE
GW Pharmaceuticals Added to NASDAQ Biotechnology Index 2:00 a.m. Dec. 22, 2014 - GlobeNewswire
Hyperion Therapeutics Added to Nasdaq Biotechnology Index (NBI) 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Revance Therapeutics Added to NASDAQ Biotechnology Index 4:06 p.m. Dec. 18, 2014 - GlobeNewswire
Cara Therapeutics Announces Addition to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 18, 2014 - GlobeNewswire
Relypsa to be Added to NASDAQ Biotechnology Index 8:01 a.m. Dec. 17, 2014 - GlobeNewswire
Alder BioPharmaceuticals Announces Addition to NASDAQ Biotechnology Index 4:02 p.m. Dec. 16, 2014 - GlobeNewswire
Kite Pharma Added to the NASDAQ Biotechnology Index 8:01 a.m. Dec. 16, 2014 - GlobeNewswire
Zafgen Added to NASDAQ Biotechnology Index 7:01 a.m. Dec. 16, 2014 - GlobeNewswire
Foundation Medicine to Be Added to NASDAQ Biotechnology Index 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Aerie Pharmaceuticals Added to NASDAQ Biotechnology Index (NBI) 6:30 a.m. Dec. 16, 2014 - BusinessWire - BZX
Cleveland Biolabs; A Diverse Play on Both Biodefense and Cancer 10:51 a.m. Nov. 13, 2014 - ACCESSWIRE
Premier Biomedical Advances Technology via Partnerships 9:29 a.m. May 9, 2014 - ACCESSWIRE
OxySure's Improving Financials & Operational Milestones Paint a Bullish Picture 8:01 a.m. March 10, 2014 - ACCESSWIRE
Regulus Announces Addition to NASDAQ Biotechnology Index 8:00 a.m. Dec. 23, 2013 - PR Newswire
Epizyme, Inc. to Be Added to NASDAQ Biotechnology Index (NBI) and NASDAQ Global Select Market 8:00 a.m. Dec. 20, 2013 - PR Newswire
KYTHERA Biopharmaceuticals Announces Addition to the NASDAQ Biotechnology Index 5:51 p.m. Dec. 19, 2013 - GlobeNewswire
Verastem Announces Addition to the NASDAQ Biotechnology Index 7:00 a.m. Dec. 19, 2013 - BusinessWire
Horizon Pharma to Be Added to NASDAQ Biotechnology Index 7:30 a.m. Dec. 17, 2013 - Marketwire
Chimerix Added to NASDAQ Biotechnology Index (NBI) 7:00 a.m. Dec. 17, 2013 - GlobeNewswire

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 6

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Crystal Risotti: Leading IT Compliance in Healthcare

Updated Category News Views 6

A Journey Marked by Dedication and Expertise In the demanding world of healthcare technology, where regulations can make or break a company, Crystal Risotti has carved out a space for herself as a leader. Over the last 30 years, she's developed a reputation for blending regulatory expertise with practical business strategies. Her recognition as a Pinnacle Professional of...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Bitwise Pulls Plug on Dogecoin ETF Amid Market Risks

Updated Category News Views 8

Bitwise Ditches Dogecoin ETF: End of a Speculative Era Who knew that a digital asset inspired by an internet meme would get a platform on Wall Street? Well, Bitwise did. They rallied behind Dogecoin, launching the Bitwise Dogecoin ETF, ticker BWOW. But as of September 10, 2026, the fund's journey is coming to an end with liquidation just around the corner. What Sparked...

Continue Reading
Lick the Plate Hits 2,000 Shows with Clown Band

Updated Category News Views 5

They say good things come in bizarre packages, and that's exactly the case as David Boylan's Lick the Plate zany celebration marks 15 years on air with its 2,000th episode. If you think of radio as a predictable endeavor, well, you're not tuned into Lick the Plate. A Milepost Draped in Multicolored Fabrics When you're browsing through colorful avenues of radio fame, it's...

Continue Reading
Americas Cardroom's Poker Series Hits $7.2M Haul

Updated Category News Views 2

Massive Prize Pools Emerge in Just Four Days I found myself eyeballing some jaw-dropping numbers from Americas Cardroom's latest poker series, the Online Super Series XL. It's not every day you see nearly a hundred tournaments rake in over $7.2 million in prize pools in just four days. From September 6th to 9th, a whopping 62,847 entries signed up to make an honest...

Continue Reading
Step Inside Henson's Creature Shop Magic in NYC

Updated Category News Views 8

Unlock Puppet Magic with Jim Henson Tours Puppet fans, let me tell you, there's something going on in Queens, NY that's got both nostalgia and innovation scribbled all over it. We're talking about the legendary Jim Henson's Creature Shop opening its doors. If you're looking to relive the magic that helped shape a generation, get ready to dive into a world where creativity...

Continue Reading
Melissa Rivers Brings Her Wit Back to Emmys Carpet

Updated Category News Views 6

They say you can never go home again, but don't tell that to Melissa Rivers. Rolling the dice on nostalgia and kicking off a new chapter, she's waltzing back to the Emmys red carpet for the first time in nearly 20 years. Alright, what's in it for investors? Not much—unless you're looking to invest in nostalgia. But there's something here about legacy, reinvention, and...

Continue Reading
BusyBee AI Revolutionizes Classroom Feedback Efficiency

Updated Category News Views 7

Grading Overhaul: BusyBee's Role in Education Here's a twist for the history books: Agilix Labs' BusyBee, a slick AI assistant built right into the Buzz platform on Amazon Bedrock, is kicking traditional grading methods to the curb. This little helper is grading close to a million K-12 student submissions every month, meticulously approved by real teachers. Quite the...

Continue Reading

Top 5 Most Recently Viewed Articles

First Industrial Realty Trust Excels in Q2 2025 Performance

Updated Category News Views 170

Strong Financial Results for First Industrial Realty Trust First Industrial Realty Trust, Inc. (NYSE: FR) announced notable financial results for its second quarter of 2025. This leading owner and operator of logistics real estate illustrated a remarkable cash same-store net operating income (NOI) growth of 8.7%, showcasing its strong market position and operational...

Continue Reading
Range Resources Announces New Quarterly Dividend

Updated Category News Views 84

Range Resources Announces New Quarterly Dividend Range Resources Corporation (NYSE: RRC) has shared some exciting news about its dividend distribution. The company's Board of Directors has officially declared a cash dividend of $0.08 per share, which is set to be distributed in the third quarter. This decision highlights Range's dedication to delivering value to its loyal...

Continue Reading
Highlights of Ringkjøbing Landbobank's Recent Buyback Program

Updated Category News Views 157

Completion of the Share Buyback Program The share buyback program initiated by Ringkjøbing Landbobank has successfully completed its target of DKK 500 million. This initiative demonstrated the bank’s commitment to enhancing shareholder value. The buybacks took place between January 28 and May 28. Details of the Transactions During the reporting period, several...

Continue Reading
Monte Rosa Therapeutics Updates on MRT-2359 Study Progress

Updated Category News Views 175

Monte Rosa Therapeutics Announces Progress in MRT-2359 Study Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a pioneering clinical-stage biotechnology company, has shared exciting updates regarding its ongoing Phase 1/2 study of MRT-2359. This innovative treatment targets MYC-driven solid tumors and has shown promising results in patient safety and drug efficacy. Key Study...

Continue Reading
Pentagon Budget Sparks AI Innovations in Defense Sector

Updated Category News Views 103

Defense Sector Transforms with AI Technologies The recent authorization of a significant $900.6 billion Pentagon budget marks the beginning of a dynamic transformation in the defense industry. This substantial financial allocation urges the need for innovation in electronic warfare and advanced sensing technologies as the complexity of modern threats increases. Experts...

Continue Reading